Table 2.
Characteristic | Q1 | Q2 | Q3 | Q4 | P-trend |
---|---|---|---|---|---|
Age, years* | 62.77±0.106 | 62.95±0.106 | 62.80±0.106 | 62.79±0.106 | 0.8500 |
Male, %* | 0.40±0.038 | 0.42±0.038 | 0.49±0.038 | 0.45±0.038 | <.0001 |
African American, %* | 0.30±0.041 | 0.23±0.044 | 0.19±0.048 | 0.14±0.055 | <.0001 |
Total cholesterol, mg/dL | 172.08±0.557 | 194.61±0.556 | 207.09±0.558 | 229.94±0.559 | <.0001 |
Triglycerides, mg/dL | 91.70±1.370 | 116.20±1.368 | 154.69±1.373 | 213.49±1.374 | <.0001 |
LDL-C, mg/dL | 97.55±0.537 | 119.30±0.537 | 129.36±0.542 | 145.64±0.551 | <.0001 |
HDL-C, mg/dL | 56.16±0.271 | 52.37±0.271 | 47.85±0.272 | 43.47±0.272 | <.0001 |
BMI, kg/m2 | 27.80±0.103 | 28.46±0.103 | 29.20±0.103 | 29.79±0.103 | <.0001 |
Smoking, % | 59±4.0 | 62±4.0 | 57±3.9 | 58±4.0 | 0.1125 |
Diabetes, % | 11.0±5.8 | 13.0±5.6 | 17.0±5.1 | 23.0±4.6 | <.0001 |
Hypertensive, % | 40.0±4.0 | 46.0±3.9 | 51.0±3.9 | 54.0±3.9 | <.0001 |
Statin use, % | 9.0±6.7 | 11.0±6.0 | 12.0±5.8 | 12.0±5.7 | <.0001 |
Metabolic syndrome, % | 23.0±4.5 | 33.0±4.0 | 50.0±3.8 | 73.0±4.3 | <.0001 |
log hs-CRP | 0.75±0.020 | 0.84±0.020 | 0.94±0.020 | 1.05±0.021 | <.0001 |
BMI: body mass index; HDL-C: high-density lipoprotein cholesterol; hs-CRP: high-sensitivity C-reactive protein; LDL-C: low-density lipoprotein cholesterol.